New treatment option for active lupus nephritis!
Clinical trials show that using voclosporin with mycophenolate mofetil is more effective at stopping lupus nephritis from getting worse than mycophenolate mofetil alone. This option is recommended for treating active class 3 to 5 lupus nephritis in adults. The cost-effectiveness estimates are within what NICE considers acceptable for NHS resources.
Recent Posts
Obesity Medication Guidelines: Evidence-Based Approaches to Effective Treatment
Obesity Medication Guidelines: ADA's Evidence-Based Framework
The American Diabetes Association (ADA) obesity medication guidelines, recently published, outline medications as integral to comprehensive obesity management f...
Equity-Based Pricing: Enhancing Value in Primary Care through Socioeconomic Considerations
Embedding Equity in Primary Care Incentives
In the English National Health Service (NHS), equity-based pricing offers a promising way to refine value-based mechanisms like the Quality and Outcomes Framework (QOF), a pay-for-performance sc...
EU Launches Joint Scientific Consultations to Enhance Health Technology Assessment
Launching Joint Scientific Consultations in 2026
The European Commission has initiated the first submission period for Joint Scientific Consultations under the EU Health Technology Assessment (HTA) Regulation. This marks the third su...